| Literature DB >> 27099669 |
Morteza Izadi1, Ali Aliakbar Esfahani2, Hadi Hassannia3, Nematollah Jonaidi Jafari1, Fatemeh Rahmati Najarkolaei1, Mohammad Saeid Rezaee-Zavareh4.
Abstract
AIM: This study aims to investigate the seroprevalence of HAV immunity among Iranian soldiers and determine whether vaccination should be given to military draftees.Entities:
Keywords: Hepatitis A virus; Military personnel; Prevalence; Seroepidemiological study
Year: 2016 PMID: 27099669 PMCID: PMC4833848
Source DB: PubMed Journal: Gastroenterol Hepatol Bed Bench ISSN: 2008-2258
Figure 1The GIS Map of HAV Seroprevalence Rates in 15 Provinces of Iran (Based on the Gathered Data of Soldiers of Different Provinces of Iran)
Age-specific seroprevalence of Anti HAV antibody in subjects
| Age group | Negative | Positive |
|---|---|---|
| < 20 | 117 (27.8%) | 304 (72.2%) |
| 20–30 | 162 (20.9%) | 616 (79.1%) |
| > 30 | 27 (7.6%) | 328 (92.4% ) |
| Total | 306 (19.7%) | 1248 (80.3%) |
Anti HAV antibody seroprevalence rate by sites of residence from different provinces of Iran
| Sites of residence | Positive | Sites of residence | Positive |
|---|---|---|---|
| Azarbaijan | 58 (92.04%) | Zanjan | 23 (58.09%) |
| Gazvin | 97 (83.64%) | Isfahan | 237 (51.21%) |
| Golestan | 13 (89.14%) | Fars | 141(52.13%) |
| Hamadan | 18 (86.29%) | Tehran | 327 (79.36%) |
| Hormozgan | 9 (87.73%) | Sistan Baluchestan | 16 (95.48%) |
| Mazandaran | 83 (73.57%) | Kerman | 23 (97.31%) |
| Khorasan | 93 (86.92%) | Yazd | 49 (89.48%) |
| Khozestan | 61 (80.65%) |